赛马鲁肽
医学
肾脏疾病
倾向得分匹配
肾功能
内科学
2型糖尿病
比例危险模型
队列
糖尿病
内分泌学
利拉鲁肽
作者
Onur Başer,Yuanqing Lu
标识
DOI:10.1080/14656566.2025.2518329
摘要
Semaglutide treatment was linked to a significantly lower risk of clinically relevant renal outcomes. Our findings provide robust real-world evidence that supports the FLOW trial results regarding the renoprotective effects of semaglutide, highlighting its promise as an effective therapeutic option for managing renal complications.
科研通智能强力驱动
Strongly Powered by AbleSci AI